The 25th Annual Procrastinators Marathon: Hot Topic Updates

Share This Event

*Registration payment includes Credit Cards and Interfund Transfers ONLY.

Target Audience

Pharmacists

Description

This knowledge-based CPE activity will provide the healthcare professional with current and emerging evidence-based updates to help ensure best practices, minimize preventable healthcare related cost, and provide optimal patient care. Focused topic discussions will include updates in many areas including Pain Management, Cardiovascular and Kidney Disease in Diabetes, Immunization Updates, COVID updates and Beta-Lactam Allergy Assessments.

Event Faculty:

Betsy Blake, PharmD, BCPS, FNAP, Clinical Associate Professor and Director of Interprofessional Education, U of SC Co-Director of Interprofessional Education for the Health Sciences and Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina

Timothy J. Ives, Pharm.D., M.P.H., FCCP, CPP UNC Eshelman School of Pharmacy and Division of General Medicine and Clinical Epidemiology, Department of Medicine, The University of North Carolina at Chapel Hill

Rupal Jaffa, PharmD, BCPS, BCIDP Clinical Pharmacist, Infectious Diseases/Antimicrobial Stewardship Antimicrobial Support Network, Division of Pharmacy Services, Atrium Health

Mabry, Erica, PharmD, Clinical Pharmacist/In-Clinic Rx, Asheville Internal Medicine Asheville, NC

Dennis Williams, PharmD, BCPS, AE-C Associate Professor, Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy


Live Webinar Information
This webinar will be broadcast with Zoom. Instructions to join the webinar will be emailed prior to the event. Please go to our live webinar requirements page for more information and to test the computer/device and network prior to the event.

Continuing Education Credit For Pharmacists:
The University Of North Carolina Eshelman School Of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program ACPE0046-9999-22-168-L01-P (Pharmacist) provides 5.5 contact hours of continuing pharmacy education credit. To receive CE credit, you must complete the CE attendance form and the evaluation of the program. Statement of credit can be viewed and printed in CPE Monitor. Statements of CE Credit will be processed in approximately 2 to 3 weeks. **No partial credit will be available**


Contact sarah.ashcraft@atriumhealth.org with questions.

Objectives

• Define deprescribing and the common reasons for dose decreasing (de-escalation)(IVES)
• Review guidelines for deprescribing medications (IVES)
• Outline a plan by which a patient may be safely dose-reduced from opioids to minimize adverse events (IVES)
• Identify new issues and updates in the pharmacotherapy for pain management (IVES)
• Describe the impact of diabetes on the risk of cardiovascular and kidney disease (BLAKE)
• Recognize the impact of social determinants of health on the development of complications from diabetes (BLAKE)
• Summarize methods to optimize the nonpharmacologic recommendations to prevent and reduce the risk of complications from diabetes (BLAKE)
• Discuss the evidence for the most recent recommendations for pharmacologic interventions to reduce the risk of cardiovascular and kidney disease related to diabetess (BLAKE)
• Identify an appropriate plan to optimize health outcomes for patients with diabetess (BLAKE)
• Review immunizations and immunization techniques for pharmacy practice (MABRY)
• Define updates of recently approved and new indications for vaccines (MABRY)
• Discuss the place in practice for recently approved and new indications for vaccines (BLAKE)
• Review the evolution and natural history of the COVID-19 (WILLIAMS)
• Describe strategies to prevent infection with SARS-CoV-2 Virus (WILLIAMS)
• Discuss the role of therapeutic therapies in the management of COVID-19 infection (WILLIAMS)
• Summarize the benefits of ß-lactam antibiotics and the pitfalls of ß-lactam allergy labels (JAFFA)
• Classify the types of allergic reactions to ß-lactams and distinguish these from intolerances (JAFFA)
• Identify patients who are appropriate for rechallenge with ß-lactam antibiotics and select an appropriate method (JAFFA)

Sessions